No definition available.
Tick-borne viral encephalitis, including avohilmo
AB1_TICK_BORNE_ENCEPHALITIS_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
235 |
4. Check minimum number of eventsNone |
235 |
5. Include endpointsNone |
235 |
6. Filter based on genotype QC (FinnGen only) |
200 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Tick-borne viral encephalitis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 200 | 112 | 88 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 57.18 | 55.94 | 58.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 218
- Matched controls
- 2180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
115.1
100
*
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
94.9
84
*
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
39.8
37
*
R50.9
ICD-10 Finland
Fever, unspecified
6.5
38.8
88
206
TAB00
NOMESCO Finland
Lumbar puncture
9.6
36.9
49
64
XA800
NOMESCO Finland
Neuropsychological investigation
10.0
35.6
45
55
A69.2
ICD-10 Finland
Lyme disease
8.3
29.2
43
63
A87.9
ICD-10 Finland
Viral meningitis, unspecified
+∞
26.6
25
*
AA1AD
NOMESCO Finland
CT of head and brain
4.3
25.4
106
391
A84
ICD-10 Finland
Tick-borne viral encephalitis
+∞
23.3
22
*
A84.1
ICD-10 Finland
Central European tick-borne encephalitis
+∞
23.3
22
*
R4120
NOMESCO Finland
Occupational therapy
5.6
18.9
40
84
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
13.7
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
11.4
129
764
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
11.3
38
114
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
11.1
40
126
B34.9
ICD-10 Finland
Viral infection, unspecified
10.0
10.8
21
23
N71
ICPC
Meningitis/encephalitis
+∞
10.5
10
*
S12
ICPC
Insect bite/sting
3.7
10.3
36
111
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.5
9.6
22
32
0632A
ICD-9 Finland
Tick-borne viral encephalitis, Central European encephalitis[PUUTIAISEN VÄLITTÄMÄ ENKEFALIITTI (KUMLINGE)]
+∞
9.4
9
*
G03.9
ICD-10 Finland
Meningitis, unspecified
26.1
7.6
10
*
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
7.3
7
*
R4110
NOMESCO Finland
Physiotherapy
2.2
6.6
75
422
J01CA04
ATC
amoxicillin; systemic
2.8
6.3
190
1548
R4150
NOMESCO Finland
Neuropsychological rehabilitation
13.0
6.1
10
8
N29
ICPC
Neurological sympt/complt other
10.5
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
79
16
76.87
142.07
1.0
1.0
—
—
—
0
0
72
19
56.09
121.45
1.1
1.5
—
—
—
0
0
82
51
25.17
102.20
1.1
1.3
69.05
2479.87
e6/l
0.54
40
39
80
50
24.70
99.32
1.1
1.2
93.11
4.94
e6/l
3.51
36
36
117
148
15.90
96.61
3.4
2.6
21.62
12.08
au/ml
0.99
23
15
112
134
16.13
95.98
1.8
1.3
61.99
22.03
au/ml
1.64
16
11
74
6
185.07
74.37
1.0
1.3
—
—
—
0
0
52
33
20.38
62.73
1.2
1.1
0.76
—
—
5
0
55
8
91.17
50.91
1.1
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
8
78.37
44.39
1.0
1.4
—
—
—
0
0
33
13
29.65
24.82
1.2
1.3
2.19
1.85
mmol/l
0.81
33
13
87
306
4.07
21.70
1.5
2.0
—
—
—
0
0
46
105
5.29
19.82
1.4
1.8
—
—
—
0
0
71
232
4.06
19.38
1.4
1.8
—
—
—
0
0
33
58
6.53
18.67
1.1
1.2
—
—
—
0
0
22
6
40.50
17.98
1.1
1.3
—
—
—
0
0
22
6
40.50
17.98
1.1
1.2
—
—
—
0
0
22
6
40.50
17.98
1.1
1.3
—
—
—
0
0
19
6
34.47
15.07
1.1
1.2
—
—
—
0
0
19
6
34.47
15.07
1.1
1.3
—
—
—
0
0
20
8
27.33
14.98
1.0
1.1
—
—
—
0
0
63
224
3.55
14.79
1.4
1.9
—
—
—
0
0
20
9
24.29
14.51
1.1
1.0
—
—
—
0
0
24
22
12.11
13.40
1.2
2.1
—
—
—
0
0
21
14
16.45
13.40
1.1
1.0
—
—
—
0
0
22
25
9.66
11.07
1.0
1.2
—
—
—
0
0
26
59
4.87
11.06
1.3
2.0
—
—
—
0
0
20
20
10.89
10.76
1.2
2.1
—
—
—
0
0
75
350
2.74
10.60
2.3
2.9
0.56
0.92
e6/l
0.94
27
172
70
319
2.76
10.32
2.5
3.1
4.01
2.11
e6/l
0.42
22
142
19
39
5.24
9.02
1.0
1.3
260.42
246.00
u/ml
0.08
12
15
97
571
2.26
7.84
2.7
3.1
0.27
0.43
e6/l
0.71
57
409
18
40
4.82
7.80
1.0
1.4
—
—
—
0
0
157
1137
2.36
7.52
8.5
10.5
4.26
4.05
e9/l
0.36
130
980
169
1269
2.48
7.36
3.1
3.2
—
—
—
0
0
127
848
2.19
7.36
6.7
6.3
1.20
1.22
mmol/l
2.38
115
792
186
1482
2.74
6.76
8.1
8.4
73.56
79.70
u/l
1.31
181
1417
144
1048
2.10
6.22
5.5
7.0
10.66
11.13
umol/l
0.33
138
1002
18
50
3.83
5.89
1.3
1.5
—
—
—
0
0
130
938
1.96
5.44
7.1
7.2
1.20
1.21
mmol/l
0.86
116
825
16
45
3.76
5.15
1.1
6.6
—
353.80
—
0
5
209
1890
3.56
4.67
19.0
15.3
20.99
23.04
mg/l
0.51
198
1546
18
60
3.18
4.51
1.2
2.2
—
—
—
0
0
17
55
3.27
4.47
1.1
1.7
—
—
—
0
0
15
39
4.05
4.29
1.0
1.3
186.00
157.65
au/ml
—
5
13
61
368
1.91
4.17
3.4
3.9
85.84
189.36
ng/l
0.56
45
280
173
1437
1.99
4.11
4.4
4.2
11.40
11.11
mm/h
0.11
167
1356
7
8
8.99
3.80
1.1
1.0
1200.86
1639.63
miu/ml
—
7
8
38
200
2.09
3.79
3.1
2.6
33.82
34.03
u/l
0.02
33
163
109
802
1.72
3.77
2.2
2.0
98.65
96.71
pmol/l
0.14
57
405
29
137
2.29
3.76
1.3
1.6
—
—
—
0
0
8
12
6.87
3.70
1.0
1.0
—
—
—
0
0
108
809
1.66
3.38
3.6
4.8
35.24
36.00
g/l
0.83
102
769
8
17
4.84
2.94
1.0
1.9
—
—
—
0
0
8
17
4.84
2.94
1.0
1.9
—
—
—
0
0
8
17
4.84
2.94
1.0
1.9
—
—
—
0
0
12
39
3.20
2.82
1.1
1.5
—
—
—
0
0
130
1050
1.59
2.80
2.9
3.8
0.00
0.00
estimate
-0.00
12
211
64
441
1.64
2.66
1.6
1.7
0.92
1.32
mg/l
0.90
45
350
128
1038
1.56
2.65
3.0
3.7
128.25
7.89
estimate
0.43
12
238
127
1031
1.56
2.59
3.0
3.7
0.00
0.00
estimate
-0.00
11
233
107
839
1.54
2.54
2.7
2.5
75.27
75.27
nmol/l
0.00
95
761
34
203
1.80
2.35
13.6
7.9
1.45
1.02
mmol/l
0.30
27
175
75
552
1.55
2.33
1.6
1.6
19.71
21.51
nmol/l
0.60
62
470
19
93
2.14
2.29
1.1
1.4
—
—
—
0
0
62
443
1.56
2.18
2.3
2.2
—
—
—
0
0
5
10
5.09
2.08
1.0
2.1
—
—
—
0
0
5
10
5.09
2.08
3.6
1.7
369.60
991.10
u/ml
—
5
10
5
10
5.09
2.08
1.0
2.1
—
—
—
0
0
5
10
5.09
2.08
1.0
2.1
—
—
—
0
0
5
10
5.09
2.08
1.0
2.1
—
—
—
0
0
22
119
1.94
2.06
18.7
7.9
25.08
24.75
mmol/l
0.20
22
119
80
611
1.49
2.05
2.1
2.5
52.04
71.98
u/l
1.20
74
575
111
912
1.44
1.92
2.9
3.0
122.42
115.03
ug/l
0.15
101
862
15
72
2.16
1.91
1.2
1.3
—
—
—
0
0
13
59
2.28
1.88
1.2
1.2
—
—
—
0
0
19
104
1.91
1.73
1.0
1.0
—
—
—
0
0
22
127
1.81
1.72
19.4
10.0
94.67
93.52
%
0.42
22
127
12
56
2.21
1.64
1.1
1.6
—
—
—
0
0
10
42
2.45
1.64
1.1
1.5
—
—
—
0
0
39
270
1.54
1.56
12.3
7.2
104.15
104.40
mmol/l
0.14
39
270
7
27
2.64
1.53
1.3
1.3
—
—
—
0
0
197
1845
1.70
1.52
18.8
15.0
87.54
83.55
ml/min/173m2
2.16
181
1698
12
58
2.13
1.52
1.1
2.0
0.00
0.00
g/l
-0.00
12
58
13
65
2.06
1.52
1.1
1.1
—
—
—
0
0
6
21
2.91
1.51
1.2
1.0
—
—
—
0
0
18
102
1.83
1.50
1.3
3.2
0.51
0.61
%
1.04
18
102
7
154
0.44
1.50
4.0
4.3
1.23
1.22
mmol/l
—
7
138
9
37
2.49
1.50
1.1
1.8
—
—
—
0
0
13
66
2.03
1.46
1.1
1.1
—
—
—
0
0
5
16
3.17
1.44
1.2
1.1
—
—
—
0
0
6
22
2.77
1.44
1.2
1.3
—
—
—
0
0
28
185
1.59
1.37
1.6
4.1
1.80
1.78
mmol/l
0.01
23
154
6
23
2.65
1.37
1.2
1.3
—
—
—
0
0
154
1385
1.38
1.36
3.2
3.3
50.92
46.60
u/l
0.29
149
1317
6
24
2.54
1.31
1.2
1.3
—
—
—
0
0
6
24
2.54
1.31
1.2
1.3
—
—
—
0
0
88
732
1.34
1.28
3.2
3.7
54.35
33.55
ng/l
0.25
63
500
65
516
1.37
1.28
2.4
2.8
334.11
341.65
umol/l
0.24
57
469
187
1746
1.50
1.28
5.7
5.3
1.68
1.92
mu/l
2.55
172
1623
25
164
1.59
1.27
1.9
2.7
0.23
0.22
g/l
0.45
25
153
162
1477
1.38
1.25
4.2
4.3
14.73
14.71
pmol/l
0.03
146
1363
9
45
2.04
1.25
1.0
1.6
—
—
—
0
0
8
37
2.21
1.23
1.3
1.5
—
—
—
0
0
8
37
2.21
1.23
1.3
1.5
—
—
—
0
0
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
17
103
1.71
1.16
1.4
3.2
0.86
1.14
%
1.63
17
103
32
228
1.47
1.14
5.7
4.7
34.12
32.18
%
0.42
17
153
28
197
1.48
1.07
6.7
7.7
—
—
—
0
0
59
476
1.33
1.03
2.2
2.1
2.99
2.75
mg/l
0.23
48
412
5
23
2.20
0.98
3.2
4.3
2.36
3.15
nmol/l
—
5
23
11
62
1.82
0.96
1.1
1.3
—
—
—
0
0
6
27
2.26
0.94
1.2
1.3
—
—
—
0
0
60
493
1.30
0.92
1.3
1.3
0.52
1.13
u/ml
2.02
13
139
8
43
1.89
0.88
1.8
1.3
—
—
—
0
0
65
544
1.28
0.87
2.7
3.2
758.21
1172.59
ng/l
1.07
54
449
212
2069
1.90
0.86
28.2
23.3
134.21
136.62
g/l
2.15
212
2055
212
2067
1.93
0.85
27.9
23.2
247.44
251.12
e9/l
0.37
207
2034
212
2067
1.93
0.85
29.8
23.6
39.86
40.80
%
1.94
212
2053
212
2067
1.93
0.85
27.9
23.2
4.46
4.54
e12/l
1.41
206
2029
212
2066
1.95
0.85
27.8
23.1
90.79
90.93
fl
0.16
212
2054
10
57
1.79
0.85
1.0
1.3
—
59.37
—
0
8
6
33
1.84
0.79
1.2
1.5
—
—
—
0
0
47
567
0.78
0.76
3.4
4.0
0.00
0.00
estimate
—
9
217
13
194
0.65
0.75
2.5
3.4
—
—
—
0
0
5
24
2.11
0.75
1.4
1.1
—
—
—
0
0
6
109
0.54
0.74
2.0
2.7
37.93
65.80
u/ml
—
6
104
23
173
1.37
0.65
1.8
1.8
3.81
3.57
mmol/l
0.40
15
126
30
237
1.31
0.62
2.0
2.1
3.50
3.59
ratio
0.14
21
195
44
366
1.25
0.62
1.3
1.3
1.35
7.71
u/ml
2.20
13
144
23
175
1.35
0.61
1.4
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
2.4
—
13.43
—
0
23
48
407
1.23
0.57
1.4
1.3
61.98
28.76
iu/ml
—
10
137
72
637
1.19
0.56
3.9
3.5
2.33
2.35
mmol/l
0.53
61
584
96
873
1.18
0.55
2.6
2.6
—
—
estimate
—
0
0
15
108
1.42
0.54
1.3
1.3
—
—
—
0
0
70
784
0.84
0.54
2.8
3.6
0.00
0.00
estimate
—
7
199
6
39
1.55
0.53
3.0
3.1
20.50
37.23
u/ml
—
6
39
17
127
1.37
0.51
1.5
2.4
—
—
—
0
0
188
1817
1.25
0.50
4.7
4.2
1.22
1.31
mmol/l
1.17
170
1699
45
392
1.19
0.42
3.7
3.1
0.44
0.74
ug/l
4.44
25
242
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
46
404
1.18
0.39
1.9
1.6
—
—
—
0
0
40
347
1.19
0.39
2.4
2.7
2.44
2.45
mmol/l
0.20
33
308
9
66
1.38
0.39
2.4
2.6
—
—
—
0
0
12
89
1.37
0.38
1.9
2.3
35.83
39.95
u/l
0.34
12
82
5
36
1.40
0.38
1.2
1.4
25.40
30.72
u/l
—
5
30
57
630
0.87
0.36
3.1
4.0
4.73
9.10
mg/mmol
1.28
33
401
6
43
1.41
0.35
1.0
1.2
—
—
—
0
0
11
82
1.36
0.35
1.7
1.6
282.64
315.24
mu/l
0.22
11
76
68
625
1.13
0.32
6.6
5.1
2.85
1.80
ug/l
0.49
57
566
7
52
1.36
0.31
1.1
1.6
—
—
—
0
0
7
52
1.36
0.31
1.3
1.8
—
—
—
0
0
53
582
0.88
0.30
2.2
3.0
0.00
0.00
estimate
—
8
189
55
501
1.13
0.30
4.1
4.5
21.04
22.25
%
0.18
19
227
32
281
1.16
0.28
1.5
1.7
744.59
1203.54
nmol/l
3.10
22
218
5
73
0.68
0.26
1.2
1.5
—
—
—
0
0
35
314
1.14
0.24
1.6
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.3
1.4
—
—
—
0
0
13
109
1.20
0.19
1.5
2.4
—
—
—
0
0
7
60
1.17
0.18
1.6
1.4
—
—
—
0
0
5
67
0.74
0.17
2.0
1.5
—
—
—
0
0
9
78
1.16
0.15
1.2
1.4
0.97
1.15
g/l
—
9
73
12
103
1.17
0.14
1.5
1.5
0.11
0.27
mg/l
—
5
42
82
850
0.94
0.13
2.2
2.0
1.49
1.40
mmol/l
0.37
66
729
47
452
1.05
0.07
2.8
3.8
1.02
1.02
kg/l
0.86
32
303
24
226
1.07
0.07
2.3
1.8
323.75
394.95
nmol/l
1.25
24
213
178
1795
0.95
0.06
6.0
6.1
38.35
39.11
mmol/mol
0.56
166
1716
191
1898
1.05
0.05
5.8
5.1
4.83
4.68
mmol/l
1.18
176
1797
182
1832
0.96
0.04
5.1
4.9
5.86
5.91
mmol/l
0.13
165
1705
25
261
0.95
0.04
1.8
2.3
—
—
—
0
0
191
1921
0.95
0.04
6.3
5.7
2.88
2.77
mmol/l
0.91
172
1815
23
239
0.96
0.03
1.7
2.2
—
—
—
0
0
190
1891
1.04
0.02
5.6
5.0
1.51
1.45
mmol/l
1.22
174
1781
163
1639
0.98
0.02
24.5
18.8
13.46
13.54
%
0.32
163
1632
5
50
1.00
0.00
1.4
1.3
0.78
0.91
nmol/l
—
5
41
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
118.14
—
0
7
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
10.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
9.99
—
0
7
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.4
—
58.37
—
0
8
0
9
0.00
-0.00
0.0
1.6
—
63.72
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
-0.00
0.0
2.3
—
107.56
—
0
9
8
79
1.01
-0.00
1.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
140.67
—
0
6
0
9
0.00
-0.00
0.0
3.6
—
0.89
—
0
9
6
60
1.00
-0.00
1.0
1.4
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.3
—
8.06
—
0
16
0
5
0.00
-0.00
0.0
1.0
—
0.25
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_TICK_BORNE_ENCEPHALITIS_WIDE – Tick-borne viral encephalitis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).